Table 2.

Experiment 2: mean exploration times ± SEM during the sample or test phase after bilateral infusions of vehicle or AP5 into the mPFC or PRH or unilateral infusions into both the PRH and mPFC in the object-in-place task (5 min delay)

Delay	Drug/side	mPFC		PRH		Unilateral mPFC and PRH
		Expl. in sample phase (s)	Expl. in test phase (s)	Expl. in sample phase (s)	Expl. in test phase (s)	Expl. in sample phase (s)	Expl. in test phase (s)
5 min	Veh	53.7 ± 4.4	20.3 ± 2.0	61.3 ± 3.6	20.5 ± 2.2
	AP5	56.1 ± 3.6	17.5 ± 2.3	58.8 ± 4.3	20.9 ± 2.4
	Ipsi					41.9 ± 2.4	12.6 ± 1.8
	Contra					36.0 ± 2.3	12.2 ± 1.4
1 h	Veh	71.5 ± 6.8	25.5 ± 2.6	48.5 ± 3.5	16.2 ± 1.9
	AP5	68.3 ± 3.4	22.9 ± 3.8	50.0 ± 2.65	17.4 ± 1.9
	Ipsi					54.9 ± 4.4	17.6 ± 2.1
	Contra					49.9 ± 2.5	18.0 ± 1.7

Expl., Exploration; Veh, vehicle.